Ten years in the life of an enzyme: the story of the human MMP-13 (collagenase-3)

References

• Freije JM, Diez-Itza I, Balbin M, Sanchez LM, Blasco R, Tolivia J, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994;269:16766–73.
   PubMed Web of Science ®Google Scholar
• Reboul P, Pelletier JP, Tardif G, Cloutier JM, Martel-Pelletier J. The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes: a role in osteoar-thritis. J Clin Invest 1996;97: 2011–9.
   Google Scholar
• Mitchell PG, Magna HA, Reeves LM, Lopresti-Morrow LL, Yocum SA, Rosner PJ, et al. Cloning, expression, and type II collagenolytic activity of matrix metalloproteinase-13 from human osteoarthritic cartilage. J Clin Invest 1996;97: 761–8.
   Google Scholar
• Wernicke D, Seyfert C, Hinzmann B, Gromnica-Ihle E. Cloning of collagenase 3 from the synovial membrane and its expression in rheumatoid arthritis and osteoarthritis. J Ftheumatol 1996;23: 590–
   Google Scholar
• Tardif G, Pelletier JP, Dupuis M, Hambor JE, Martel-Pelletier J. Cloning, sequencing and characterization of the S'-flanking region of the human collagenase-3 gene. Biochem J 1997;323: 13–6.
   Google Scholar
• Pendas AM, Balbin M, Llano E, Jimenez MG, Lopez-Otin C. Structural analysis and promoter characterization of the human collagenase-3 gene (MMP-13). Genomics 1997;40: 222–33.
   Google Scholar
• Henriet P, Rousseau GG, Eeckhout Y. Cloning and sequencing of mouse collagenase cDNA. Divergence of mouse and rat collagena-ses from the other mammalian collagenases. FEBS Lett 1992;310: 175–8.
   Google Scholar
• Quinn CO, Scott DK, Brinckerhoff CE, Matrisian LM, Jeffrey JJ, Partridge NC. Rat collagenase. Cloning, amino acid sequence com-parison, and parathyroid hormone regulation in osteoblastic cells. J Biol Chem 1990;265:22342–7.
   Google Scholar
• Knauper V, Bailey L, Worley JR, Soloway P, Patterson ML, Murphy G. Cellular activation of proMMP-13 by MT1-MMP de-pends on the C-terminal domain of MMP-13. FEBS Lett 2002;532: 127–30.
   PubMed Web of Science ®Google Scholar
• Gomis-Ruth FX, Gohlke U, Betz M, Knauper V, Murphy G, Lopez-Otin C, et al. The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain. J Mol Biol 1996;264: 556–66.
   Google Scholar
• Knauper V, Will H, Lopez-Otin C, Smith B, Atkinson SJ, Stanton H, et al. Cellular mechanisms for human procollagenase-3 (MMP-13) activation. Evidence that MT1-MMP (MMP-14) and gelatinase a (MMP-2) are able to generate active enzyme. J Biol Chem 1996;271: 17124–31.
   Google Scholar
• Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996;271:1544–50.
   PubMed Web of Science ®Google Scholar
• Moilanen M, Sorsa T, Stenman M, Nyberg P, Lindy 0, Vesterinen J, et al. Tumor-associated trypsinogen-2 (trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and stromelysin-1 (MMP-3) and degrades type I collagen. Biochemistry 2003;42: 5414–20.
   Google Scholar
• Gomez DE, Alonso DF, Yoshiji H, Thorgeirsson UP. Tissue in-hibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol 1997;74:111–22.
   PubMed Web of Science ®Google Scholar
• Letavic MA, Barberia JT, Carty TJ, Hardink JR, Liras J, Lopresti-Morrow LL, et al. Synthesis and biological activity of piperazine-based dual MMP-13 and TNF-alpha converting enzyme inhibitors. Bioorg Med Chem Lett 2003;13: 3243–6.
   Google Scholar
• Reiter LA, Mitchell PG, Martinelli GJ, Lopresti-Morrow LL, Yocum SA, Eskra JD. Phosphinic acid-based MMP-13 inhibitors that spare MMP-1 and MMP-3. Bioorg Med Chem Lett 2003;13: 2331–6.
   Google Scholar
• Dahlberg L, Billinghurst RC, Manner P, Nelson F, Webb G, Ionescu M, et al. Selective enhancement of collagenase-mediated cleavage of resident type II collagen in cultured osteoarthritic car- tilage and arrest with a synthetic inhibitor that spares collagenase 1 (matrix metalloproteinase 1). Arthritis Rheum 2000;43:673–82.
   PubMed Web of Science ®Google Scholar
• Billinghurst RC, Wu W, Ionescu M, Reiner A, Dahlberg L, Chen J, et al. Comparison of the degradation of type II collagen and proteoglycan in nasal and articular cartilages induced by inter-leukin-1 and the selective inhibition of type II collagen cleavage by collagenase. Arthritis Rheum 2000;43:664–72.
   PubMed Web of Science ®Google Scholar
• Billinghurst RC, Dahlberg L, Ionescu M, Reiner A, Bourne R, Rorabeck C, et al. Enhanced cleavage of type II collagen by colla-genases in osteoarthritic articular cartilage. J Clin Invest 1997;99: 1534–45.
   PubMed Web of Science ®Google Scholar
• Knauper V, Cowell S, Smith B, Lopez-Otin C, O'Shea M, Morris H, et al. The role of the C-terminal domain of human collagenase-3 (MMP-13) in the activation of procollagenase-3, substrate spe-cificity, and tissue inhibitor of metalloproteinase interaction. J Biol Chem 1997;272: 7608–16.
   Google Scholar
• Fosang AJ, Last K, Knauper V, Murphy G, Neame PJ. Degrada-tion of cartilage aggrecan by collagenase-3 (MMP-13). FEBS Lett 1996;380: 17–20.
   Google Scholar
• Hashimoto G, Inoki I, Fujii Y, Aoki T, Ikeda E, Okada Y. Matrix metalloproteinases cleave connective tissue growth factor and re-activate angiogenic activity of vascular endothelial growth factor 165. J Biol Chem 2002;277:36288–95.
   PubMed Web of Science ®Google Scholar
• Hiller 0, Lichte A, Oberpichler A, Kocourek A, Tschesche H. Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase im-pair clotting by degradation of fibrinogen and factor XII. J Biol Chem 2000;275: 33008–13.
   Google Scholar
• Stahle-Backdahl M, Sandstedt B, Bruce K, Lindahl A, Jimenez MG, Vega JA, et al. Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remod-eling and in rheumatoid arthritis. Lab Invest 1997;76: 717–28.
   Google Scholar
• Johansson N, Saarialho-Kere U, Airola K, Herva R, Nissinen L, Westermarck J, et al. Collagenase-3 (MMP-13) is expressed by hypertrophic chondrocytes, periosteal cells, and osteoblasts during human fetal bone development. Dev Dyn 1997;208:387–97.
   PubMed Web of Science ®Google Scholar
• Bau B, Gebhard PM, Haag J, Knorr T, Bartnik E, Aigner T. Relative messenger RNA expression profiling of collagenases and aggrecanases in human articular chondrocytes in vivo and in vitro. Arthritis Rheum 2002;46:2648–57.
   PubMed Web of Science ®Google Scholar
• Otterness IG, Bliven ML, Eskra JD, te Koppele JM, Stukenbrok HA, Milici AJ. Cartilage damage after intraarticular exposure to collagenase 3. Osteoarthritis Cartilage 2000;8: 366–73.
   Google Scholar
• Neuhold LA, Killar L, Zhao W, Sung ML, Warner L, Kulik J, et al. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J Clin Invest 2001;107:35–44.
   PubMed Web of Science ®Google Scholar
• Shlopov BV, Lie WR, Mainardi CL, Cole AA, Chubinskaya S, Hasty KA. Osteoarthritic lesions: involvement of three different collagenases. Arthritis Rheum 1997;40:2065–74.
   PubMed Web of Science ®Google Scholar
• Moldovan F, Pelletier JP, Hambor J, Cloutier JM, Martel-Pelletier J. Collagenase-3 (matrix metalloprotease 13) is preferentially lo-calized in the deep layer of human arthritic cartilage in situ: In vitro mimicking effect by transforming growth factor beta. Arthritis Rheum 1997;40: 1653–61.
   Google Scholar
• Tetlow LC, Adlam DJ, Woolley DE. Matrix metalloproteinase and proinflammatory cytokine production by chondrocytes of human osteoarthritic cartilage: associations with degenerative changes. Arthritis Rheum 2001;44:585–94.
   Google Scholar
• Freemont AJ, Byers RJ, Taiwo YO, Hoyland JA. In situ zymo-graphic localisation of type II collagen degrading activity in osteoarthritic human articular cartilage. Ann Rheum Dis 1999;58: 357–65.
   PubMed Web of Science ®Google Scholar
• Fernandes JC, Martel-Pelletier J, Lascau-Coman V, Moldovan F, Jovanovic D, Raynauld JP, et al. Collagenase-1 and collagenase-3 synthesis in early experimental osteoarthritic canine cartilage. An immunohistochemical study. J Ftheumatol 1998;25:1585–94.
   Google Scholar
• Walling HW, Chan PT, Omura TH, Barmina OY, Fiacco GJ, Jeffrey JJ, et al. Regulation of the collagenase-3 receptor and its role in intracellular ligand processing in rat osteoblastic cells. J Cell Physiol 1998;177:563–74.
   PubMed Web of Science ®Google Scholar
• Barmina OY, Walling HW, Fiacco GJ, Freije JM, Lopez-Otin C, Jeffrey JJ, et al. Collagenase-3 binds to a specific receptor and requires the low-density lipoprotein receptor-related protein for internalization. J Biol Chem 1999;274: 30087–93.
   Google Scholar
• Walling HW, Raggatt LJ, Irvine DW, Barmina OY, Toledano JE, Goldring MB, et al. Impairment of the collagenase-3 endocytotic receptor system in cells from patients with osteoarthritis. Osteo-arthritis Cartilage 2003;11:854–63.
   PubMed Web of Science ®Google Scholar
• Westhoff CS, Freudiger D, Petrow P, Seyfert C, Zacher J, Kriegsmann J, et al. Characterization of collagenase 3 (matrix metalloproteinase 13) messenger RNA expression in the synovial membrane and synovial fibroblasts of patients with rheumatoid arthritis. Arthritis Rheum 1999;42:1517–27.
   PubMedGoogle Scholar
• Petrow PK, Wernicke D, Schulze Westhoff C, Hummel KM, Brauer R, Kriegsmann J, et al. Characterisation of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis. Ann Rheum Dis 2002;61:391–7.
   PubMed Web of Science ®Google Scholar
• Lindy 0, Konttinen YT, Sorsa T, Ding Y, Santavirta S, Ceponis A, et al. Matrix metalloproteinase 13 (collagenase 3) in human rheumatoid synovium. Arthritis Rheum 1997;40: 1391–9.
   Google Scholar
• Tetlow LC, Woolley DE. Comparative immunolocalization studies of collagenase 1 and collagenase 3 production in the rheumatoid lesion, and by human chondrocytes and synoviocytes in vitro. Br J Ftheumatol 1998;37:64–70.
   PubMedGoogle Scholar
• Konttinen YT, Ainola M, Valleala H, Ma J, Ida H, Mandelin J, et al. Analysis of 16 different matrix metalloproteinases (MMP-1 to MMP-20) in the synovial membrane: different profiles in trauma and rheumatoid arthritis. Ann Rheum Dis 1999;58:691–7.
   PubMed Web of Science ®Google Scholar
• Konttinen YT, Salo T, Hanemaaijer R, Valleala H, Sorsa T, Sutinen M, et al. Collagenase-3 (MMP-13) and its activators in rheumatoid arthritis: localization in the pannus-hard tissue junc-tion and inhibition by alendronate. Matrix Biol 1999;18:401–12.
   PubMed Web of Science ®Google Scholar
• Uria JA, Balbin M, Lopez JM, Alvarez J, Vizoso F, Takigawa M, et al. Collagenase-3 (MMP-13) expression in chondrosarcoma cells and its regulation by basic fibroblast growth factor. Am J Pathol 1998;153:91–101.
   PubMed Web of Science ®Google Scholar
• Elnemr A, Yonemura Y, Bandou E, Kinoshita K, Kawamura T, Takahashi S, et al. Expression of collagenase-3 (matrix metallo-proteinase-13) in human gastric cancer. Gastric Cancer 2003; 6:30–8.
   PubMedGoogle Scholar
• Hattori Y, Nerusu KC, Bhagavathula N, Brennan M, Hattori N, Murphy HS, et al. Vascular expression of matrix metallopro-teinase-13 (collagenase-3) in basal cell carcinoma. Exp Mol Pathol 2003;74:230–7.
   PubMed Web of Science ®Google Scholar
• Johansson N, Airola K, Grenman R, Kariniemi AL, Saarialho-Kere U, Kahari VM. Expression of collagenase-3 (matrix metalloproteinase-13) in squamous cell carcinomas of the head and neck. Am J Pathol 1997;151: 499–508.
   Google Scholar
• Airola K, Johansson N, Kariniemi AL, Kahari VM, Saarialho-Kere UK. Human collagenase-3 is expressed in malignant squa-mous epithelium of the skin. J Invest Dermatol 1997;109: 225–331.
   Google Scholar
• Cazorla M, Hernandez L, Nadal A, Balbin M, Lopez JM, Vizoso F, et al. Collagenase-3 expression is associated with advanced local invasion in human squamous cell carcinomas of the larynx. J Pathol 1998;186:144–50.
   PubMed Web of Science ®Google Scholar
• Johansson N, Vaalamo M, Grenman S, Hietanen S, Klemi P, Saarialho-Kere U, et al. Collagenase-3 (MMP-13) is expressed by tumor cells in invasive vulvar squamous cell carcinomas. Am J Pathol 1999;154: 469–80.
   Google Scholar
• Pendas AM, Uria JA, Jimenez MG, Balbin M, Freije JP, Lopez-Otin C. An overview of collagenase-3 expression in malig-nant tumors and analysis of its potential value as a target in anti-tumor therapies. Clin Chim Acta 2000;291: 137–55.
   Google Scholar
• Ala-aho R, Grenman R, Seth P, Kahari VM. Adenoviral delivery of p53 gene suppresses expression of collagenase-3 (MMP-13) in squamous carcinoma cells. Oncogene 2002;21: 1187–95.
   Google Scholar
• Ala-Aho R, Johansson N, Baker AH, Kahari VM. Expression of collagenase-3 (MMP-13) enhances invasion of human fibrosar-coma HT-1080 cells. Int J Cancer 2002;97: 283–9.
   Google Scholar
• Nyberg P, Heikkila P, Sorsa T, Luostarinen J, Heljasvaara R, Stenman UH, et al. Endostatin inhibits human tongue carcinoma cell invasion and intravasation and blocks the activation of matrix metalloprotease-2, -9, and -13. J Biol Chem 2003;278:22404–11.
   PubMed Web of Science ®Google Scholar
• Binder C, Hagemann T, Husen B, Schulz M, Einspanier A. Relaxin enhances in vitro invasiveness of breast cancer cell lines by up-regulation of matrix metalloproteases. Mol Hum Reprod 2002;8: 789–96.
   Google Scholar
• Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C, et al. Candidate genes for the hypoxic tumor phenotype. Cancer Res 2000;60:883–7.
   PubMed Web of Science ®Google Scholar
• Kiili M, Cox SW, Chen HW, Wahlgren J, Maisi P, Eley BM, et al. Collagenase-2 (MMP-8) and collagenase-3 (MMP-13) in adult periodontitis: molecular forms and levels in gingival crevicular fluid and immunolocalisation in gingival tissue. J Clin Periodontol 2002;29:224–32.
   PubMed Web of Science ®Google Scholar
• Li de Q, Shang TY, Kim HS, Solomon A, Lokeshwar BL, Pflugfelder SC. Regulated expression of collagenases MMP-1, -8, and -13 and stromelysins MMP-3, -10, and -11 by human corneal epithelial cells. Invest Ophthalmol Vis Sci 2003;44:2928–36.
   PubMedGoogle Scholar
• Vaalamo M, Mattila L, Johansson N, Kariniemi AL, Karjalainen-Lindsberg ML, Kahari VM, et al. Distinct populations of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers, but not in normally healing wounds. J Invest Dermatol 1997;109: 96–101.
   Google Scholar
• Uitto VJ, Airola K, Vaalamo M, Johansson N, Putnins EE, Firth JD, et al. Collagenase-3 (matrix metalloproteinase-13) expression is induced in oral mucosal epithelium during chronic inflammation. Am J Pathol 1998;152:1489–99.
   PubMed Web of Science ®Google Scholar
• Jeng AY, Chou M, Sawyer WK, Caplan SL, Von Linden-Reed J, Jeune M, et al. Enhanced expression of matrix metalloproteinase-3, -12, and -13 mFtNAs in the aortas of apolipoprotein E-deficient mice with advanced atherosclerosis. Ann NY Acad Sci 1999;878: 555–8.
   Google Scholar
• Yoon S, Kuivaniemi H, Gatalica Z, Olson JM, Buttice G, Ye S, et al. MIMP13 promoter polymorphism is associated with athero-sclerosis in the abdominal aorta of young black males. Matrix Biol 2002;21:487–98.
   PubMed Web of Science ®Google Scholar
• Pendas AM, Matilla T, Estivill X, Lopez-Otin C. The human collagenase-3 (CLG3) gene is located on chromosome 11q22.3 clustered to other members of the matrix metalloproteinase gene family. Genomics 1995;26: 615–8.
   Google Scholar
• Tardif G, Dupuis M, Reboul P, Geng CS, Pelletier JP, Ranger P, et al. Identification and differential expression of human collagenase-3 mFtNA species derived from internal deletion, alternative splic-ing, and different polyadenylation and transcription initiation sites. Osteoarthritis Cartilage 2003;11:524–37.
   PubMed Web of Science ®Google Scholar
• Tardif G, Reboul P, Dupuis M, Changshan G, Duval N, Pelletier JP, et al. TGF-beta-induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by SMAD proteins: coop-eration between AP-1 and PEA-3 binding sites. J Ftheumatol 2001;28:1631–9.
   Google Scholar
• Benderdour M, Tardif G, Pelletier J, Di Battista JA, Reboul P, Ranger P, et al. Interleukin-17 (IL-17) induces collagenase-3 production in human osteoarthritic chondrocytes via an AP-1-dependent activation: differential activation of AP-1 members by IL-17 and IL-1(3. J. Ftheumatol 2002;29: 1262–72.
   Google Scholar
• Jimenez MJ, Balbin M, Lopez JM, Alvarez J, Komori T, Lopez-Otin C. Collagenase 3 is a target of Cbfal, a transcription factor of the runt gene family involved in bone formation. Mol Cell Biol 1999;19: 4431–42.
   Google Scholar
• Benderdour M, Tardif G, Pelletier J-P, Dupuis M, Geng C, Martel-Pelletier J. A novel negative regulatory element in the human collagenase-3 proximal promoter region. Biochem Biophys Res Commun 2002;291: 1151–9.
   Google Scholar
• Sun Y, Cheung JM, Martel-Pelletier J, Pelletier JP, Wenger L, Altman RD, et al. Wild-type and mutant p53 differentially regulate the gene expression of human collagenase-3 (hMIMP-13). J Biol Chem 2000;275: 11327–32.
   Google Scholar
• Yamanishi Y, Boyle DL, Pinkoski MJ, Mahboubi A, Lin T, Han Z, et al. Regulation of joint destruction and inflammation by p53 in collagen-induced arthritis. Am J Pathol 2002;160:123–30.
   PubMed Web of Science ®Google Scholar
• Liacini A, Sylvester J, Li WQ, Huang W, Dehnade F, Ahmad M, et al. Induction of matrix metalloproteinase-13 gene expression by TNF-alpha is mediated by MAP kinases, AP-1, and NF-kappaB transcription factors in articular chondrocytes. Exp Cell Res 2003;288:208–17.
   PubMed Web of Science ®Google Scholar
• Mengshol JA, Vincenti MP, Coon CI, Barchowsky A, Brinckerhoff CE. Interleukin-1 induction of collagenase 3 (matrix metallo-proteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase, and nuclear factor kappaB: differential regula-tion of collagenase 1 and collagenase 3. Arthritis Rheum 2000;43: 801–11.
   Google Scholar
• Liacini A, Sylvester J, Li WQ, Zafarullah M. Inhibition of inter-leukin-l-stimulated MAP kinases, activating protein-1 (AP-1) and nuclear factor kappa B (NF-kappa B) transcription factors down-regulates matrix metalloproteinase gene expression in articular chondrocytes. Matrix Biol 2002;21:251–62.
   PubMed Web of Science ®Google Scholar
• Mengshol JA, Vincenti MP, Brinckerhoff CE. IL-1 induces collagenase-3 (MMP-13) promoter activity in stably transfected chondrocytic cells: requirement for Runx-2 and activation by p38 MAPK and JNK pathways. Nucleic Acids Res 2001;29: 4361–72.
   Google Scholar
• Angel P, Karin M. Specific members of the Jun protein family regulate collagenase expression in response to various extracellu-lar stimuli. Matrix Suppl 1992;1:156–64.
   PubMedGoogle Scholar
• Tardif G, Pelletier JP, Dupuis M, Geng C, Cloutier JM, Martel-Pelletier J. Collagenase 3 production by human osteoar-thritic chondrocytes in response to growth factors and cytokines is a function of the physiological state of the cells. Arthritis Rheum 1999;42: 1147–58.
   Google Scholar
• Johansson N, Westermarck J, Leppd S, Häkkinen L, Koivisto L, Lopez-Otin S, et al. Collagenase 3 (matrix metalloproteinase 13) gene expression by HaCaT keratinocytes is enhanced by tumor necrosis factor-a and transforming growth factor43. Cell Growth Differ 1997;8: 243–50.
   Google Scholar
• Ravanti L, Hakkinen L, Larjava H, Saarialho-Kere U, Foschi M, Han J, et al. Transforming growth factor-beta induces collagenase-3 expression by human gingival fibroblasts via p38 mitogen-activated protein kinase. J Biol Chem 1999;274: 37292–300.
   Google Scholar
• Johansson N, Ala-aho R, Uitto V, Grenman R, Fusenig NE, Lopez-Otin C, et al. Expression of collagenase-3 (MMP-13) and collagenase-1 (MMP-1) by transformed keratinocytes is dependent on the activity of p38 mitogen-activated protein kinase. J Cell Sci 2000;113:227–35.
   PubMed Web of Science ®Google Scholar
• Uria JA, Jimenez MG, Balbin M, Freije JMP, Lopez-Otin C. Dif-ferential effects of transforming growth factor-beta on the expres-sion of collagenase-1 and collagenase-3 in human fibroblasts. J Biol Chem 1998;273: 9769–77.
   Google Scholar
• Leivonen SK, Chantry A, Hakkinen L, Han J, Kahari VM. Smad3 mediates transforming growth factor-beta-induced collagenase-3 (matrix metalloproteinase-13) expression in human gingival fibroblasts. Evidence for cross-talk between Smad3 and p38 signal-ing pathways. J Biol Chem 2002;277: 46338–46.
   Google Scholar
• Selvamurugan N, Fung Z, Partridge NC. Transcriptional activation of collagenase-3 by transforming growth factor-betal is via MAPK and Smad pathways in human breast cancer cells. FEBS Lett 2002;532: 31–5.
   Google Scholar
• Reboul P, Pelletier JP, Tardif G, Benderdour M, Ranger P, Bottaro DP, et al. Hepatocyte growth factor induction of collage-nase 3 production in human osteoarthritic cartilage: involvement of the stress-activated protein kinase/c-Jun N-terminal kinase pathway and a sensitive p38 mitogen-activated protein kinase inhibitor cascade. Arthritis Rheum 2001;44:73–84.
   PubMedGoogle Scholar
• Forsyth CB, Pulai J, Loeser FtF. Fibronectin fragments and block-ing antibodies to alpha-2-beta-1 and alpha-5-beta-1 integrins stimulate mitogen-activated protein kinase signaling and increase collagenase 3 (matrix metalloproteinase 13) production by human articular chondrocytes. Arthritis Rheum 2002;46: 2368–76.
   Google Scholar
• Loeser FtF, Forsyth CB, Samarel AM, Im HJ. Fibronectin frag-ment activation of proline-rich tyrosine kinase PYK2 mediates integrin signals regulating collagenase-3 expression by human chondrocytes through a protein kinase C-dependent pathway. J Biol Chem 2003;278:24577–85.
   PubMed Web of Science ®Google Scholar
• Yasuda T, Shimizu M, Nakagawa T, Julovi SM, Nakamura T. Matrix metalloproteinase production by CO OH-terminalheparin-binding fibronectin fragment in rheumatoid synovial cells. Lab Invest 2003;83:153–62.
   Google Scholar
• Li WQ, Dehnade F, Zafarullah M. Oncostatin M-induced matrix metalloproteinase and tissue inhibitor of metalloproteinase-3 genes expression in chondrocytes requires Janus kinase/STAT sig-naling pathway. J Immunol 2001;166: 3491–8.
   Google Scholar
• Roy-Beaudry M, Martel-Pelletier J, Pelletier JP, M'Barek KN, Christgau S, Shipkolye F, et al. Endothelin-1 promotes osteoar-thritic cartilage degradation via matrix metalloprotease-1 and matrix metalloprotease-13 induction. Arthritis Rheum 2003;48: 2855–64.
   PubMedGoogle Scholar
• Roy-Beaudry M, Martel-Pelletier J, Pelletier JP, Nait M'Barek K, Christgau S, Shipkolye F, et al. Endothelin-1 promotes osteoar-thritic cartilage degradation via MMP-1 and MMP-13 induction [Abstract]. Arthritis Rheum 2003;48:569.
   PubMedGoogle Scholar
• Bai G, Howell DS, Howard GA, Roos BA, Cheung HS. Basic calcium phosphate crystals up-regulate metalloproteinases but down-regulate tissue inhibitor of metalloproteinase-1 and -2 in human fibroblasts. Osteoarthritis Cartilage 2001;9: 416–22.
   Google Scholar
• Tetlow LC, Woolley DE. Histamine stimulates matrix metallo-proteinase-3 and -13 production by human articular chondrocytes in vitro. Ann Rheum Dis 2002;61:737–40.
   PubMed Web of Science ®Google Scholar
• Im HJ, Pacione C, Chubinskaya S, Van Wijnen AJ, Sun Y, Loeser FtF. Inhibitory effects of insulin-like growth factor-1 and osteo-genic protein-1 on fibronectin fragment- and interleukin-1 -beta-stimulated matrix metalloproteinase-13 expression in human chondrocytes. J Biol Chem 2003;278: 25386–94.
   Google Scholar
• Fahmi H, Di Battista JA, Pelletier JP, Mineau F, Ranger P, Martel-Pelletier J. Peroxisome proliferator-activated receptor gamma acti-vators inhibit interleukin-1 -beta-induced nitric oxide and matrix metalloproteinase-13 production in human chondrocytes. Arthritis Rheum 2001;44: 595–607.
   Google Scholar
• Ala-aho R, Johansson N, Grenman R, Fusenig NE, Lopez-Otin C, Kahari VM. Inhibition of collagenase-3 (MMP-13) expression in transformed human keratinocytes by interferon-gamma is associ-ated with activation of extracellular signal-regulated kinase-1,2 and STAT1. Oncogene 2000;19: 248–57.
   Google Scholar
• Heikkila P, Teronen 0, Moilanen M, Konttinen YT, Hanemaaijer R, Laitinen M, et al. Bisphosphonates inhibit stromelysin-1 (MMP-3), matrix metalloelastase (MMP-12), collagenase-3 (MMP-13) and enamelysin (MMP-20), but not urokinase-type plasminogen activator, and diminish invasion and migration of human malignant and endothelial cell lines. Anticancer Drugs 2002;13: 245–54.
   Google Scholar
• Sun HB, Yokota H. Altered mFtNA level of matrix metallo-sproteinase-13 in MH7A synovial cells under mechanical loading and unloading. Bone 2001;28:399–403.
   PubMed Web of Science ®Google Scholar
• Sun HB, Nalim R, Yokota H. Expression and activities of matrix metalloproteinases under oscillatory shear in IL-1-stimulated synovial cells. Connect Tissue Res 2003;44: 42–9.
   Google Scholar
• Yokota H, Goldring MB, Sun HB. CITED2-mediated regulation of MMP-1 and MMP-13 in human chondrocytes under flow shear. J Biol Chem 2003;278: 47275–80.
   Google Scholar
• Wong M, Siegrist M, Goodwin K. Cyclic tensile strain and cyclic hydrostatic pressure differentially regulate expression of hyper-trophic markers in primary chondrocytes. Bone 2003;33:685–93.
   Google Scholar
• Yu Q, Cok SJ, Zeng C, Morrison AR. Translational repression of human matrix metalloproteinases-13 by an alternatively spliced form of T-cell-restricted intracellular antigen-related protein (TIAR). J Biol Chem 2003;278:1579–84.
   PubMed Web of Science ®Google Scholar